Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment - Concepedia

Concepedia

Publication | Open Access

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment

DOI Full Paper Access

135

Citations

33

References

2007

Year

Maxime Bréban, Philippe Ravaud, Pascal Claudepierre, Gabriel Baron, Yves‐Dominique Henry, Christophe Hudry, Liana Euller‐Ziegler, Thao Pham, Elisabeth Solau‐Gervais, Isabelle Chary‐Valckenaere,

Arthritis & Rheumatism

Abstract

These findings indicate that continuous treatment of AS with infliximab is more efficacious than on-demand treatment, and that the addition of MTX to infliximab provides no significant benefit.

References

	Year	Citations
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. John E. Ware, Cathy D. Sherbourne PubMed Quality Of LifeHealth OutcomeItem Response TheoryGeriatric MedicinePrimary Care	1992	34K
The MOS 36-ltem Short-Form Health Survey (SF-36) John E. Ware, Cathy D. Sherbourne Medical Care NursingQuality Of LifePrimary CareHealth PolicyHealthy Aging	1992	29.1K
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis Sjef van der Linden, Hans A. Valkenburg, A. Cats Arthritis & Rheumatism	1984	5.6K
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. Sylvester Garrett, T Jenkinson, L G Kennedy, PubMed	1994	3.2K
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. A Cãlin, H Whitelock, L G Kennedy, PubMed	1994	1.8K
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Arthritis & Rheumatism	1998	1.6K
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial Jürgen Braun, J. Brandt, Joachim Listing, The Lancet InflammationRheumatologyAnti-inflammatorySpondyloarthritisChronic Musculoskeletal Condition	2002	1.3K
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens, Arthritis & Rheumatism	2005	855
Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis Jennifer J. Anderson, Gabriel Baron, Désirée van der Heijde, Arthritis & Rheumatism	2001	608
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease Séverine Vermeire, M. Noman, Gert Van Assche, Gut	2007	599

Page 1